International announces new cancer centre
PROTON Partners International has
announced plans to build a new ₤35 million cancer treatment centre in Liverpool.
The cancer centre will be built in the new ₤1 billion Paddington Village, part
of Liverpool's Knowledge Quarter (KQ).
This will be 1 of 4 centres built by Proton Partners International in the UK and
will make the company the world's largest developer of proton beam therapy
centres. Proton Partners International is currently building 3 other UK Cancer Centres, in Newport, Northumberland and Reading, and is considering
The Oncology Centre, which will be known, as:-
'The Rutherford Cancer Centre North West,' will offer radiotherapy, chemotherapy
and imaging from 2018, and proton beam therapy will be available in 2019.
Joe Anderson, Mayor of Liverpool, said:- "We are delighted KQ Liverpool
has been able to attract another prestigious development to Paddington Village.
Momentum is really beginning to build for KQ Liverpool and we can expect more
exciting announcements like Proton Partners International's, which will further
cement its reputation as a world leading hub in medical and life sciences
Mike Moran, chief executive officer of Proton
Partners International, said:- "I am delighted to announce that our 4th UK
Centre is to be in my home City of Liverpool. Not only will we be bringing the
top cancer technology to the North West, but we will be located at heart of what
will be a world class destination for science, innovation, education and
technology. This investment will not only enhance the level of cancer treatment
available to patients, but will also bring skilled jobs to the area."
It is expected The Rutherford Cancer Centres will each be able to treat up to
500 patients a year and treatment will be available to medically insured private
patients, self paying patients and patients referred by the NHS.
Proton Partners International is also building a genomics research centre at the
Life Sciences Accelerator building in Liverpool which will be the 1st part of
a health campus set to surround the ₤335m new Royal Liverpool Hospital. The
genomics programme will support Proton Partners International's broader research
work with the University of Liverpool's Physics Department.